Cited by 262PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerMuscle Physiology and Disorders

Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1

Open access
Wang, Hongmei, Kubica, Neil, Ellisen, Leif W., Jefferson, Leonard S., Kimball, Scot R.·2006·Journal of Biological Chemistry

Abstract

The mammalian target of rapamycin (mTOR), a critical modulator of cell growth, acts to integrate signals from hormones, nutrients, and growth-promoting stimuli to downstream effector mechanisms involved in the regulation of protein synthesis. Dexamethasone, a synthetic glucocorticoid that represses protein synthesis, acts to inhibit mTOR signaling as assessed by reduced phosphorylation of the downstream targets S6K1 and 4E-BP1. Dexamethasone has also been shown in one study to up-regulate the expression of REDD1 (also referred to RTP801, a novel stress-induced gene linked to repression of mTOR signaling) in lymphoid, but not nonlymphoid, cells. In contrast to the findings of that study, here we demonstrate that REDD1, but not REDD2, mRNA expression is dramatically induced following acute dexamethasone treatment both in rat skeletal muscle in vivo and in L6 myoblasts in culture. In L6 myoblasts, the effect of the drug on mTOR signaling is efficiently blunted in the presence of REDD1 RNA interference oligonucleotides. Moreover, the dexamethasone-induced assembly of the mTOR regulatory complex Tuberin. Hamartin is disrupted in L6 myoblasts following small interfering RNA-mediated repression of REDD1 expression. Finally, overexpression of Rheb, a downstream target of Tuberin function and a positive upstream effector of mTOR, reverses the effect of dexamethasone on phosphorylation of mTOR substrates. Overall, the data support the conclusion that REDD1 functions upstream of Tuberin and Rheb to down-regulate mTOR signaling in response to dexamethasone.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m610023200

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Rannels, D. E., Rannels, S. R., Li, J. B., Pegg, A. E., Morgan, H. E., and Jefferson, L. S. (eds) (1980) Advances in Myocardiology, pp. 493-501, Uni- versity Park Press, Baltimore
  2. Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., and Blenis, J. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 13571-13576

Cited by

Sorted by citations

Authors
Wang, H., Kubica, N., Ellisen, L. W., Jefferson, L. S., & Kimball, S. R.
Affiliations
  • Pennsylvania State University (US)
  • Harvard University (US)
Corresponding author
Kimball, Scot R.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-12
Volume
281
Issue
51
Pages
39128-39134
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2080447685
Cited by
262
References
4
Citations by year
2026: 6 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 17 · 2020: 14 · 2019: 15 · 2018: 12 · 2017: 11 · 2016: 15 · 2015: 17 · 2014: 13 · 2013: 17 · 2012: 22
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Pennsylvania Department of Health
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-15658, R01DK015658)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
dexamethasone, mTOR signaling, REDD1, skeletal muscle, L6 myoblasts, Rheb, S6K1, 4E-BP1, protein synthesis regulation, glucocorticoids, RNA interference
MeSH terms
Ras Homolog Enriched in Brain Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Dexamethasone, DNA-Binding Proteins, Gene Expression Regulation, Glucocorticoids, Male, Neuropeptides, Protein Kinases, Repressor Proteins, RNA, Messenger, Transcription Factors, Signal Transduction, Rats, Sprague-Dawley, Muscle, Skeletal, Monomeric GTP-Binding Proteins, Tumor Suppressor Proteins, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review